Table Of Contents
1 Introduction 10
1.1 Objectives Of The Study 10
1.2 Market Definition 10
1.3 Overview Of France Flow Cytometry Market 11
1.4 Currency And Pricing 11
1.5 Limitation 11
1.6 Markets Covered 12
2 Market Segmentation 14
2.1 Markets Covered 14
2.2 Years Considered For The Study 15
2.3 Currency And Pricing 15
2.4 Research Methodology 16
2.5 Primary Interviews With Key Opinion Leaders 19
2.6 DBMR Market Position Grid 20
2.7 DBMR Market Challenge Matrix 21
2.8 Secondary Sources 22
2.9 Assumptions 22
3 Market Overview 23
3.1 Drivers 25
3.1.1 Advent Of Advanced Technologies In Flow Cytometry 25
3.1.2 Increased Occurrences Of HIV/AIDSAnd Cancer 26
3.1.3 Rising Adoption Of Flow Cytometry Techniques In Clinical Testing, Pharmaceutical Studies, Research And Clinical Applications 27
3.2 Restraints 28
3.2.1 Lack Of Skilled Professionals 28
3.2.2 High Costing Involved In Flow Cytometry 28
3.3 Opportunity 29
3.3.1 Emergence Of High-Throughput Flow Cytometry Technology 29
3.3.2 Increasing Usage Of Flow Cytometry In Stem Cell Research 30
3.4 Challenges 31
3.4.1 Insufficient Availability Of Infrastructure In Emerging Markets 31
4 Executive Summary 32
5 Premium Insights 35
6 France Flow Cytometry Market, By End User 37
6.1 Overview 38
6.2 Cell-Based Flow Cytometry 39
6.3 Bead-Based Flow Cytometry 40
7 France Flow Cytometry Market, By Products 41
7.1 Overview 42
7.2 Reagents And Consumables 45
7.2.1 Antibodies 45
7.2.2 Dyes 45
7.2.3 Beads 45
7.2.4 Others 45
7.3 Flow Cytometry Instruments 46
7.3.1 Cell Analyzers 46
7.3.2 Cell Sorters 46
7.4 Accessories 47
7.4.1 Filters 47
7.4.2 Laser Device 47
7.4.3 Detectors 47
7.4.4 Others 47
7.5 Services 48
8 France Flow Cytometry Market, By Application 49
8.1 Overview 50
8.2 Research Applications 52
8.2.1 Pharmaceutical And Biotechnology 53
8.2.1.1 Drug Discovery 53
8.2.1.2 Stem Cell Research 54
8.2.1.3 In Vitro Toxicity Testing 54
8.2.2 Immunology 54
8.2.3 Apoptosis 54
8.2.4 Cell Sorting/ Screening 55
8.2.5 Cell Cycle Analysis 55
8.2.6 Cell Transfection/Viability 55
8.2.7 Cell Counting 55
8.2.8 Others 56
8.3 Clinical Applications 56
8.3.1 Cancer 57
8.3.2 Hematology 57
8.3.3 Immunodeficiency Diseases 57
8.3.4 Organ Transplantation 57
8.3.5 Other Clinical Applications 58
8.4 Industrial Applications 58
9 France Flow Cytometry Market, By End User 59
9.1 Overview 60
9.2 Academic & Research Institutes 62
9.3 Hospitals & Clinical Testing Laboratories 62
9.4 Pharmaceutical & Biotechnology Companies 63
10 France Flow Cytometry Market, Company Landscape 64
10.1 Company Share Analysis; France 64
11 Company Profile 65
11.1 Bd. 65
11.1.1 Company Overview 65
11.1.2 Revenue Analysis 65
11.1.3 Product Portfolio 66
11.1.4 Recent Developments 68
11.2 Merck Kgaa 70
11.2.1 Company Overview 70
11.2.2 Revenue Analysis 70
11.2.3 Product Portfolio 71
11.2.4 Recent Developments 71
11.3 Bio-Rad Laboratories, Inc. 72
11.3.1 Company Overview 72
11.3.2 Revenue Analysis 72
11.3.3 Product Portfolio 73
11.3.4 Recent Developments 74
11.4 Thermo Fisher Scientific Inc. 75
11.4.1 Company Overview 75
11.4.2 Revenue Analysis 75
11.4.3 Product Portfolio 76
11.4.4 Recent Developments 76
11.5 Biom?rieux Sa 77
11.5.1 Company Overview 77
11.5.2 Revenue Analysis 77
11.5.3 Product Portfolio 78
11.5.4 Recent Developments 78
?
11.6 Acea Bio 79
11.6.1 Company Overview 79
11.6.2 Geographic al Presence 79
11.6.3 Product Portfolio 80
11.6.4 Recent Developments 80
11.7 Apogee Flow Systems Ltd. 81
11.7.1 Company Overview 81
11.7.2 Product Portfolio81
11.8 Beckman Coulter, Inc. 82
11.8.1 Company Overview 82
11.8.2 Geographic al Presence 82
11.8.3 ProductPortfolio 83
11.8.4 Recent Developements 84
11.9 Enzo Life Sciences, Inc. 85
11.9.1 Company Overview 85
11.9.2 Geographic al Presence 85
11.9.3 ProductPortfolio 86
11.9.4 Recent Developements 86
11.10 Luminex Corporation. 87
11.10.1 Company Overview 87
11.10.2 Revenue Analysis 87
11.10.3 Product Portfolio 88
11.10.4 Recent Developments 88
11.11 Mechatronics 89
11.11.1 Company Overview 89
11.11.2 Geographic al Presence 89
11.11.3 Product Portfolio 90
11.12 Miltenyi Biotec 91
11.12.1 Company Overview 91
11.12.2 Geographic al L Presence 91
11.12.3 Product Portfolio 92
11.12.4 Recent Developments 93
11.13 Sony Biotechnology Inc. 94
11.13.1 Company Overview 94
11.13.2 Geographic al Presence 94
11.13.3 Product Portfolio 95
11.13.4 Recent Developments 96
?
11.14 Stratedigm, Inc. 97
11.14.1 Company Overview 97
11.14.2 Product Portfolio 97
11.15 Sysmex Partec Gmbh (A Subsidary Of Sysmex Corporation) 98
11.15.1 Company Overview 98
11.15.2 Geographic al Presence 98
11.15.3 Product Portfolio 99
11.15.4 Recent Developments 100
11.16 Takara Bio Inc. 101
11.16.1 Company Overview 101
11.16.2 Revenue Analysis 101
11.16.3 Product Portfolio 102
11.16.4 Recent Developments 102
12 Related Reports 103
?